Similar articles

• Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.

  Moghimi SM. Moghimi SM. Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5. Mol Ther. 2021. PMID: 33571463 Free PMC article. Review. No abstract available.
• Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?

  Azenha Rama T, Álvarez-Twose I. Azenha Rama T, et al. J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12. J Investig Allergol Clin Immunol. 2021. PMID: 33574015 No abstract available.
• COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.

  Peter J. Peter J. S Afr Med J. 2021 Feb 8;111(4):291-294. doi: 10.7196/SAMJ.2021.v111i4.15576. S Afr Med J. 2021. PMID: 33944757
• [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].

  Worm M, Ring J, Klimek L, Jakob T, Lange L, Treudler R, Beyer K, Werfel T, Biedermann T, Bircher A, Fischer M, Fuchs T, Heller AR, Hoffmann F, Huttegger I, Kopp MV, Kugler C, Lommatzsch M, Pfaar O, Rietschel E, Rueff F, Schnadt S, Seifert R, Stöcker B, Vogelberg C, Sitter H, Gieler U, Brockow K. Worm M, et al. MMW Fortschr Med. 2021 Jan;163(1):48-51. doi: 10.1007/s15006-021-9530-6. MMW Fortschr Med. 2021. PMID: 33464512 Free PMC article. Review. German. No abstract available.
• mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

  Rama TA, Moreira A, Castells M. Rama TA, et al. J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19. J Allergy Clin Immunol. 2021. PMID: 33485650 Free PMC article. No abstract available.